The ROE as of October 2024 (TTM) for Alpine Immune Sciences, Inc. (ALPN) is -14.86%

According to Alpine Immune Sciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -14.86%. This represents a change of 219.75% compared to the average of -4.65% of the last 4 quarters.

Alpine Immune Sciences, Inc. (ALPN) Historical ROE (quarterly & annually)

How has ALPN ROE performed in the past?

The mean historical ROE of Alpine Immune Sciences, Inc. over the last ten years is -35.32%. The current -14.86% ROE has changed -57.93% with respect to the historical average. Over the past ten years (40 quarters), ALPN's ROE was at its highest in in the December 2014 quarter at 22.13%. The ROE was at its lowest in in the June 2020 quarter at -61.18%.

Alpine Immune Sciences, Inc. (ALPN) ROE by Quarter and Year

Discovering the peaks and valleys of Alpine Immune Sciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alpine Immune Sciences, Inc. (ALPN) Average ROE

How has ALPN ROE performed in the past?

The current ROE of Alpine Immune Sciences, Inc. (ALPN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Alpine Immune Sciences, Inc. (ALPN) ROE vs. Peers

How is ALPN’s ROE compared to its peers?

Alpine Immune Sciences, Inc.’s ROE is less than Terns Pharmaceuticals, Inc. (0%), greater than Day One Biopharmaceuticals, Inc. (-39.58%), greater than Acumen Pharmaceuticals, Inc. (-22.40%), greater than Amylyx Pharmaceuticals, Inc. (-24.63%), greater than MoonLake Immunotherapeutics (-46.15%), greater than Anebulo Pharmaceuticals, Inc. (-11.05%), greater than Adagene Inc. (-138.92%), greater than Acrivon Therapeutics, Inc. Common Stock (-50.10%), greater than AnaptysBio, Inc. (-47.31%), greater than Mineralys Therapeutics, Inc. (-255.67%), greater than Tenaya Therapeutics, Inc. (-42.61%), greater than Bicycle Therapeutics plc (-80.97%), greater than IGM Biosciences, Inc. (-27.35%), greater than Monte Rosa Therapeutics, Inc. (-119.02%), greater than Stoke Therapeutics, Inc. (-70.40%), greater than null (-57.89%),

Build a custom stock screener for Alpine Immune Sciences, Inc. (ALPN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alpine Immune Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alpine Immune Sciences, Inc. (ALPN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alpine Immune Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.